Literature DB >> 10084264

Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.

A Ghavamzadeh1, K Alimoghadam, P Nasseri, M Jahani, A Khodabandeh, G Ghahremani.   

Abstract

Dyskeratosis congenita is recognized by its dermal lesions and constitutional aplastic anemia in some cases. We report successful allogeneic bone marrow transplantation in two siblings with this disease from their sister, and their long term follow-up. We used reduced doses of cyclophosphamide and busulfan for conditioning instead of total body irradiation. Also, we report late adverse effects of transplantation which are not distinguishable from the natural course of disease.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10084264     DOI： 10.1038/sj.bmt.1701567

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  7 in total

1.  The gastrointestinal manifestations of telomere-mediated disease.

Authors:  Naudia L Jonassaint; Nini Guo; Joseph A Califano; Elizabeth A Montgomery; Mary Armanios
Journal:  Aging Cell       Date:  2013-01-04       Impact factor: 9.304

2.  Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.

Authors:  Elizabeth O Stenger; Kuang-Yueh Chiang; Ann Haight; Muna Qayed; Leslie Kean; John Horan
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-19       Impact factor: 5.742

3.  Genetic and environmental factors influencing human diseases with telomere dysfunction.

Authors:  Hinh Ly
Journal:  Int J Clin Exp Med       Date:  2009-05-31

Review 4.  Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.

Authors:  Suneet Agarwal
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

5.  A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Adam S Nelson; Rebecca A Marsh; Kasiani C Myers; Stella M Davies; Sonata Jodele; Tracey A O'Brien; Parinda A Mehta
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-01       Impact factor: 5.742

6.  Long-term functional engraftment of mesenchymal progenitor cells in a mouse model of accelerated aging.

Authors:  Lakshman Singh; Tracy A Brennan; Jung-Hoon Kim; Kevin P Egan; Emily A McMillan; Qijun Chen; Kurt D Hankenson; Yi Zhang; Stephen G Emerson; F Brad Johnson; Robert J Pignolo
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

7.  Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.

Authors:  A C Dietz; P J Orchard; K S Baker; R H Giller; S A Savage; B P Alter; J Tolar
Journal:  Bone Marrow Transplant       Date:  2010-04-12       Impact factor: 5.174
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.